Skip to main navigation

Vertex Websites

Choose your region

Americas
- Canada
- United States
Asia Pacific
- Australia
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
Middle East
- GCC
Rest of the world
- Global / EN

Don't see your region/country
listed? Visit our global website

Choose your region

Newsroom
Press Releases
News Alert

Newsroom
Press Releases
News Alert

Media Library

Corporate Images
Corporate Logos
Headshots
Reports and Resources
Videos

Media inquiries:

mediainfo@vrtx.com

+1 617 341 6992

+44 20 3204 5275

Newsroom

Newsroom

Leadership team

Latest Press Releases

View all

Apr 06, 2026

Vertex to Announce First Quarter 2026 Financial Results on May 4th

Apr 01, 2026

Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States

Mar 09, 2026

Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy

View all

Featured Media Library Items

View all

Reshma Kewalramani, M.D.

Reshma Kewalramani, M.D.

Chief Executive Officer and President

Download

Duncan McKechnie

Duncan McKechnie

Executive Vice President and Chief Commercial Officer

Download

Vertex International Headquarters – Lobby

Vertex International Headquarters – Lobby

Download

View all

Newsroom Home
Press Releases
Media Library

Privacy
Terms of Use
Your Privacy Choices

Facebook
Twitter
LinkedIn
Instagram
Youtube

© 2026 Vertex Pharmaceuticals Incorporated